Combination therapy for malaria in Africa: hype or hope?
about
Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand borderAntimalarial drug resistanceArtemisinin-based combination therapies: a vital tool in efforts to eliminate malariaEfficacy of pyrimethamine-sulfadoxine in young children with uncomplicated falciparum malaria in rural Burkina FasoEffect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South AfricaResearch influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.Intermittent preventive treatment of malaria during pregnancy: a qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District, North-Eastern TanzaniaSafety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina FasoA database of antimalarial drug resistance.Novel 4-aminoquinoline-pyrimidine based hybrids with improved in vitro and in vivo antimalarial activity.Elevated levels of IL-10 and G-CSF associated with asymptomatic malaria in pregnant womenDefining Plasmodium falciparum treatment in South West Asia: a randomized trial comparing artesunate or primaquine combined with chloroquine or SPInhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virusPerceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study.From chloroquine to artemisinin-based combination therapy: the Sudanese experience.Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya.Knowledge and malaria treatment practices using artemisinin combination therapy (ACT) in Malawi: survey of health professionals.Evaluation of Effectiveness of Ethanolic Extract of Artemisia aucheri, Individually and in Combination with Chloroquine, on Chloroquine - Sensitive Strain of Plasmodium berghei in Sourian Mice.Antimelanoma Potential of Eruca sativa Seed Oil and its Bioactive PrinciplesAdherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, EthiopiaEfficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'ZérékoréThe challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.Therapeutic Efficacy of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Northern Ethiopia.Analyzing Thiol-Dependent Redox Networks in the Presence of Methylene Blue and Other Antimalarial Agents with RT-PCR-Supported in silico Modeling.Efficacy of amodiaquine in the treatment of uncomplicated falciparum malaria in young children of rural north-western Burkina Faso.Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, TanzaniaMalaria research and its influence on anti-malarial drug policy in Malawi: a case study.Adverse drug events resulting from use of drugs with sulphonamide-containing anti-malarials and artemisinin-based ingredients: findings on incidence and household costs from three districts with routine demographic surveillance systems in rural TanzUnsweetened Natural Cocoa Powder Has the Potential to Attenuate High Dose Artemether-Lumefantrine-Induced Hepatotoxicity in Non-Malarious Guinea PigsFactors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural SenegalSustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study.Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania.Chloroquine Resistant Plasmodium falciparum in Nigeria: Relationship between pfcrt and pfmdr1 Polymorphisms, In-Vitro Resistance and Treatment Outcome.In Vitro antibacterial efficacy of 21 Indian timber-yielding plants against multidrug-resistant bacteria causing urinary tract infection.Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum.Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies.Trends in malaria morbidity following the introduction of artesunate plus amodiaquine combination in M'lomp village dispensary, south-western Senegal.World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibility.Impact of Extended Duration of Artesunate Treatment on Parasitological Outcome in a Cytocidal Murine Malaria Model.
P2860
Q21032539-2EF93E90-C06E-4030-BB7B-100CCC0E95CDQ22061790-FF454259-BBB6-4113-AFE8-B375DD7FD12CQ24614989-71457198-1DB2-441B-A499-135328779FBAQ24803565-2F0ADA1F-FE71-4EC2-A354-D0C652D7734CQ24810617-5ADC150F-2C5C-4CE4-82EF-808D05E9A54CQ24814023-D770A22B-C56E-47AA-AFE4-2E3C7BCC380BQ24814180-87A3A561-AC18-4293-8805-2E3EBE866423Q24815501-C127ED0E-DA21-4249-8258-9E5F2CC660E6Q28472182-02F75E13-2A5E-47F8-9A77-B12AF0E86C32Q30483123-4793B9EA-568F-46FE-A61F-A6C1C3410586Q33630451-EF8DD9A1-3B0F-409E-A08C-2D205A539EB3Q34034202-A52E8F61-2231-4322-B1C1-8093A7DA3325Q34149975-3B62DBE0-0F80-4AD5-84C7-229037010C2FQ34354703-CF70B756-F2B6-4F1B-8146-5D8C382E256FQ35030048-C5E22904-8C24-4E2D-9C7B-62A935220435Q35065971-798DC945-05C0-48AF-9A12-71F223B6652FQ35299140-3458E06D-E7DF-4CB8-9545-1469E761F32CQ35390088-E208C8D2-9CB0-4F12-8CD5-AB2D3ADF47BDQ35639234-3E090906-6AB8-497F-915C-1BA862C79B96Q35641273-4A74FDB6-78FC-4C1E-B6E1-4C832CA07744Q35642797-AB0A894F-AF49-40F6-8DF7-4FDD464A9486Q35791172-D688CBC0-9163-45FB-B44B-6C1EBFAC1024Q35842358-1321481C-BC91-41B3-AC81-5F046876CE86Q35919321-D46B8283-2581-40AE-8586-B2525095EB1FQ36450015-9C9CB965-BA60-45CF-8DDA-51BF83319843Q36606690-1C86EFE1-E1BB-442D-AA4A-F6E3517D9430Q36797637-BC84F81D-AAF3-4309-A2AC-BF54ECBBCFB3Q36955257-B2A676F1-2692-43C8-A128-15DFFAFDDA6CQ37009500-96D8F331-D48A-46A6-A1AD-9D534DAF0852Q37132237-DCE5AF22-2F23-42A4-820A-3646E22EA258Q37223641-8E5C5AA9-AD71-4C43-ACCD-0841327B9DAEQ37261150-9C660597-8984-42FD-A131-202A639B826CQ37289589-95FDABFC-1E57-421D-B0F9-BD2F518E2CCAQ37445582-2F41E4E3-367A-4811-9D01-F7C9C0F6435BQ37579696-3854754E-6747-4A11-A70C-105EF3BE9D71Q37598726-2485F211-7B15-4BCC-84A8-1FA71B3DD159Q39363372-5E864618-A0A5-44B8-A8D2-3C1D8F8E65F3Q39432114-B25A55B0-6902-4F41-B620-5DD185A311C0Q41410017-48332F83-C467-4EC0-82BC-9E1A673D6C11Q41695336-6DA686C3-EF5E-4184-8702-0D92A96FA349
P2860
Combination therapy for malaria in Africa: hype or hope?
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Combination therapy for malaria in Africa: hype or hope?
@ast
Combination therapy for malaria in Africa: hype or hope?
@en
Combination therapy for malaria in Africa: hype or hope?
@nl
type
label
Combination therapy for malaria in Africa: hype or hope?
@ast
Combination therapy for malaria in Africa: hype or hope?
@en
Combination therapy for malaria in Africa: hype or hope?
@nl
prefLabel
Combination therapy for malaria in Africa: hype or hope?
@ast
Combination therapy for malaria in Africa: hype or hope?
@en
Combination therapy for malaria in Africa: hype or hope?
@nl
P2093
P1476
Combination therapy for malaria in Africa: hype or hope?
@en
P2093
P304
P407
P577
2000-01-01T00:00:00Z